| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 981.805.434 $ | +241.457.877 $ | +8,4 % | 4 | 834.980.337 $ | +90.561.546 $ | +17,4 % | 5 | 744.418.791 $ | +317.168.117 $ | +77,1 % | 5 | ||||
| Centessa Pharmaceuticals plc | CNTA | → 0 | 792.936.596 $ | +293.658.039 $ | +58,8 % | 1 | 499.278.557 $ | +15.172.000 $ | +3,1 % | 1 | 484.106.557 $ | +221.790.674 $ | +84,6 % | 1 | |
| Phathom Pharmaceuticals, Inc. | PHAT | → 0 | Neutral | 82.931.395 $ | -40.905.854 $ | -33,0 % | 1 | 123.837.249 $ | +35.979.237 $ | +41,0 % | 1 | 87.858.012 $ | +16.272.767 $ | +22,7 % | 1 |
| NewAmsterdam Pharma Co N.V. | NAMS | → 0 | Schwach | 85.600.566 $ | -15.063.774 $ | -15,0 % | 1 | 100.664.340 $ | +19.053.911 $ | +23,3 % | 1 | 81.610.429 $ | +29.642.607 $ | +57,0 % | 1 |
| RAPT Therapeutics, Inc. | RAPT | → 0 | 94.632.780 $ | +22.575.520 $ | +31,3 % | 1 | 72.057.260 $ | +49.705.260 $ | +222,4 % | 1 | |||||
| Aura Biosciences, Inc. | AURA | → 0 | Schwach | 20.336.877 $ | +3.769.466 $ | +22,8 % | 1 | 16.567.411 $ | -2.219.122 $ | -11,8 % | 1 | 18.786.533 $ | -243.191 $ | -1,3 % | 1 |
| 981.805.434 $ | +241.457.877 $ | +8,4 % | 4 | 834.980.337 $ | +90.561.546 $ | +17,4 % | 5 | 744.418.791 $ | +317.168.117 $ | +77,1 % | 5 | ||||